[Effects of tobacco smoke on fetus and children]

Takashi Noda1

  • 1Noda Children's Clinic.

Insights

Parental smoking, particularly maternal smoking, harms fetal development, leading to conditions like oral cleft and low birth weight. It also increases children's risk of respiratory illnesses, accidents, and future smoking, impacting lifelong health.

Area of Science:

  • Pediatrics
  • Public Health
  • Developmental Toxicology

Context:

  • Parental smoking poses significant risks to child development and well-being.
  • Exposure during critical developmental periods can have lasting consequences.
  • Understanding these risks is crucial for preventative strategies.

Purpose:

  • To outline the adverse effects of parental smoking on fetal and child health.
  • To highlight the link between parental smoking and developmental issues.
  • To emphasize the long-term health implications for children exposed to smoke.

Summary:

  • Maternal smoking is linked to oral clefts, impacting infant feeding.
  • Parental smoking increases risks for respiratory illnesses like asthma and accidents.
  • Low birth weight from parental smoking is a risk factor for adult lifestyle-related diseases (DOHaD hypothesis).
  • Parental smoking encourages children to become active smokers, leading to poor lifestyle choices and metabolic syndrome.

Impact:

  • Reducing parental smoking can prevent birth defects and improve infant health.
  • Interventions targeting parental smoking cessation can mitigate risks of childhood illness and injury.
  • Preventing childhood initiation of smoking through parental example is vital for long-term public health.
  • Addressing parental smoking supports the DOHaD (Developmental Origins of Health and Disease) hypothesis, promoting healthier futures.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...